INTRODUCTION {#sec1-1}
============

Samul-tang (*Si-Wu-tang* in Chinese, *Shimotsu-to in* Japanese); composed of *Angelicae gigantis* Radix, Cnidii Rhizoma, Paeonia Radix, and Rehmanniae Radix in the Korean Pharmacopoeia; has been traditionally used to treat cardiovascular, gynecologic, cutaneous, and chronic inflammation disorders.\[[@ref1]\] Recently, Samul-tang was reported to exert anti-inflammatory, antiallergic, and antipruritic properties.\[[@ref2],[@ref3]\] Major bioactive components in Samul-tang are well-known to contain phenolics (e.g. gallic acid, ferulic acid), terpene glycosides (e.g. albiflorin, paeoniflorin, paenol), phthalides (e.g. Z-ligustilide, senkyunolide A, ligustrazine, butylphthalide), and iridoid glycosides (e.g. catalpol).\[[@ref1],[@ref4]\] However, although herbal medicines in Samul-tang contain various coumarin compounds, there is little information about them. Especially, many researchers found that *Angelica gigantis* Radix contain coumarin compounds such as nodakenin, nodakenetin, decursinol, decursinol angelate, and decursin.\[[@ref5],[@ref6],[@ref7]\] These coumarin compounds have various biological properties including anticancer, anti-inflammatory, antibacterial, and antioxidant activities.\[[@ref8],[@ref9],[@ref10]\] To provide helpful information for the pharmacological and clinical effect of Samul-tang, the pharmacokinetic study of coumarin compounds and a quantitative analytical method for the determination of coumarin compounds are required.

According to the literature, several high-performance liquid chromatography ultraviolet (HPLC-UV)\[[@ref11]\] and HPLC/electrospray ionization mass spectrometry (ESI-MS) method\[[@ref7],[@ref12]\] were used to determine the coumarin compounds in single herbs and to analyze their preparation. In addition, several HPLC-UV\[[@ref13],[@ref14],[@ref15],[@ref16]\] and HPLC/ESI-MS method\[[@ref5]\] to determine nodakenin, nodakenetin, and decursin/decursinol angelate were developed and validated in animal plasma and tissue. However, there is no analytical method to determine five coumarin compounds simultaneously and to apply the pharmacokinetics of those compounds, although the mixture of those compounds in single herbal medicines and formulations were commonly used. In this study, a simple and sensitive HPLC-UV method for determining five coumarin compounds in rat plasma was developed, validated, and successfully applied to pharmacokinetic study of coumarins in Samul-tang.

MATERIALS AND METHODS {#sec1-2}
=====================

Chemicals and reagents {#sec2-1}
----------------------

Nodakenin, nodakenetin, decursinol, and decursin and decursinol angelate obtained from Korea Food and Drug Administration (KFDA, Osong, South Korea). Isoliquiritin used as an internal standard (IS) were purchased from Wako Chemicals (Osaka, Japan). The chemical structures of five coumarin compounds and IS are shown in [Figure 1](#F1){ref-type="fig"}. HPLC-grade acetonitrile, methanol, and water were purchased from J.T. Baker Inc. (Philipsburg, NJ, USA). Other chemicals with analytical grade were purchased from Sigma-Aldrich Inc.

![Chemical structures of the five coumarin compounds ((a) nodakenin; (b) nodakenetin; (c) decursin; (d) decursinol angelate; (e) decursinol) and isoliquiritin ((f), IS)](PM-10-34-g001){#F1}

All herbal medicines were purchased from Yeongcheon traditional herbal market (Yeongcheon, South Korea). Samul-tang was prepared in accordance with the method previously described.\[[@ref17]\] Brownish powder (403.5 ± 5.4 g) of Samul-tang was obtained and stored at 4°C before use. The amounts of nodakenin, nodakenetin, decursinol, and decursin/decursinol angelate in Samul-tang were 2.29 ± 0.14, 0.08 ± 0.01, 0.094 ± 0.01, and 5.24 ± 0.12 mg/g extract, respectively, according to previous report.\[[@ref7]\]

Chromatographic condition and sample preparation {#sec2-2}
------------------------------------------------

Plasma concentrations of five coumarin compounds were determined using a HPLC system (Lachrom Elite, Hitach High-Technologies Corp, Tokyo, Japan) equipped an binary pump, an autosampler, a column oven, and a diode array detector. The analytes and IS were separated on a Phenomenex Luna C~18~ column (4.6 mm × 250 mm, 5.0 μm, Torrance, CA, USA) and eluted with a gradient of deionized water (A) and acetonitrile (B). The gradient elution was programmed as follows: 35-50% (v/v) B at 0-6 min; 50-100% B at 6-14 min; 100-100% B at 14.0-18.0 min. The column temperature was 30°C and the flow rate was 1.0 mL/min.

The analytes and IS in rat plasma was extracted with a liquid-liquid extraction (LLE) method. One hundred microliters of plasma samples, 100 μL of acetonitrile, and 10 μL of IS (2.0 μg/mL) were mixed. The mixture was vortexed for 5 min and then centrifuged at 10,000 g for 10 min. Then 20 μL of aliquot was injected into the HPLC system. All analytes were detected at 330 nm.

Preparation of stock solution, calibration samples, and quality control samples {#sec2-3}
-------------------------------------------------------------------------------

Standard stock solutions of analytes and IS were prepared by dissolving 1 mg/mL in methanol. Especially, decursin and decursinol angelate (1:1, v/v) were mixed at each concentration of 0.5 mg/mL. Working solutions were freshly prepared by serial dilutions in methanol. Calibration samples were prepared by 10 μL of working solutions in 90 μL of drug-free rat plasma to obtain final concentrations in the range of 0.1-10.0 μg/mL for nodakenin and 0.05-10.0 μg/mL for nodakenetin, decursinol, and decursin/decursinol angelate. QC samples were prepared at low, medium, and high concentration of 0.1, 0.5, and 5.0 μg/mL, respectively, in the same manner.

Method validation {#sec2-4}
-----------------

Drug-free rat plasma were analyzed for the determination of any endogenous interferences at the peak region of each analyte and IS comparing the plasma spiked analytes and IS.

The calibration curves were constructed with linear least squares regression and demonstrated the linearity of this method, based on the peak area ratio of analytes and IS. The lower limit of quantification (LLOQ, signal-to-noise ratio \>10) was defined as the lowest concentration of analytes the lowest concentration at which the analytes can be quantified with an accuracy of ± 15% and a precision ≤20%.

QC samples for the determination of intraday accuracy and precision were freshly prepared and analyzed on the same day. For interday accuracy and precision, the analyses of QC samples were repeated for four consecutive days. Accuracy was calculated as the percent error (bias, %) between the measured concentration and the nominal concentration of QC samples. Precision expressed as relative standard deviation (RSD, %).

Recoveries of analytes were determined by comparing the peak area ratio of analytes and IS of QC samples to that of intact working standard in methanol. QC samples at three concentrations were used by analyzing in triplicate. Stability of analytes in rat plasma was tested with QC samples which were stored under different temperature conditions (room temperature and -20°C) for the desired time. Subsequently, postpreparative stability was evaluated using the prepared samples after storage at 4°C for 24 h.

Application of pharmacokinetics {#sec2-5}
-------------------------------

Animal experiment was approved from the Institutional Animal Care and Use Committee of Korea Institute of Oriental Medicine (Daejeon, South Korea). Ten male Sprague-Dawley rats (260-280 g) were obtained from Samtaco (Osan, South Korea). After acclimation in a controlled environment for 1 week, rats were randomly divided into two-dose groups (*n* = 5). After the preparation of Samul-tang in distilled water, the animals were administered by single oral gavage (2.5 or 10 g/kg). Blood samples (300 μL) were collected from the caudal vein at 0, 20, and 40 min and 1, 2, 3, 4, 6, 8, 12, 14, 18, 20, 24, 30, 36, and 48 h after administration. The blood samples were collected in ethylediaminetetraacetic acid (EDTA)-contained tubes and centrifuged at 4,000 × g for 10 min. The plasma samples were stored at -20°C prior to uses and were analyzed within 2 weeks after plasma sampling. The noncompartmental pharmacokinetic analysis was performed using PKSolver program.\[[@ref18]\]

RESULTS AND DISCUSSION {#sec1-3}
======================

Optimization of chromatographic condition and sample preparation {#sec2-6}
----------------------------------------------------------------

Several mobile phases were applied to separate analytes and IS in biological matrix including deionized water, 0.1% trifluoroacetic acid (TFA), 0.1% acetic acid, acetonitrile, and methanol. Finally, deionized water and acetonitrile were chosen as mobile phases with a gradient elution because of good separation and short chromatographic cycle. In addition, Gemini C~18~ (4.6 mm × 100 mm, 3.0 μm, Phenomenex, CA, USA), Agilent Eclips Plus C~18~ (4.6 mm × 100 mm, 3.5 μm, Agilent, Santa Clara, CA, USA), and TSKgel ODS-100V C~18~ (4.6 mm × 250 mm, 5.0 μm, TOSOH, Tokyo, Japan) column were compared. The Phenomenex Luna C~18~ column was selected on the basis of relatively short retention time, good peak shape, and excellent selectivity. The wavelength (330 nm) of detection and IS was chosen, based on UV spectrum of analytes and validation procedures.

Validation of HPLC method {#sec2-7}
-------------------------

### Selectivity {#sec3-1}

The HPLC chromatograms of a blank plasma sample, a blank plasma sample spiked with analytes, and plasma sample after oral administration of Samul-tang were shown in [Figure 2](#F2){ref-type="fig"}. Each peak of analytes in plasma was identified by comparing retention time and UV spectra of each standard. The retention times of nodakenin, nodakenetin, decursinol, decursin/decursinol angelate, and IS were 4.407, 7.893, 8.527, 13.107, and 11.147 min, respectively. There was no endogenous interference during the elution of all analytes and IS.

![Representative chromatogram of coumarin compounds (1, nodakenin; 2, nodakenetin; 3, decursinol; 4, decursin/decursinol angelate). (a) blank plasma; (b) blank plasma spiked with the five coumarins; (c) plasma sample of the rat at 4 h after oral administration of Samul-tang](PM-10-34-g002){#F2}

### Linearity and LLOQ {#sec3-2}

Calibration curves with good linearity were covered in a wide linear range. The mean regression equations were *y* = 0.605x + 0.0098 (r^2^ \< 0.999) for nodakenin, *y* = 1.002x + 0.0216 (r^2^ \< 0.999) for nodakenetin, y = 0.987x + 0.0195 (r^2^ \<0.999) for decursinol, and *y* = 0.926x + 0.0188 (r^2^ \<0.999) for decursin/decursinol angelate. The LLOQ of nodakenin, nodakenetin, decursinol, and decursin/decursinol angelate were 0.1, 0.05, 0.05, and 0.05 μg/mL, respectively. In this study, the calibration curves were in a sufficient range and sensitivity for pharmacokinetics of five coumarin compounds.

### Accuracy and precision {#sec3-3}

In the present study, intra- and interday accuracy and precision with QC samples at three concentrations (0.1, 0.5, and 5.0 μg/mL) were evaluated and summarized in [Table 1](#T1){ref-type="table"}. The results indicated that this HPLC method is accurate and highly reproducible.

###### 

Precision and accuracy for coumarin compounds in rat plasma

![](PM-10-34-g003)

### Recovery and stability {#sec3-4}

In this study, LLE method was used for the preparation of plasma sample. Various solvents, such as methanol, acetonitrile, ethyl acetate, and dichloromethane were tested for the extraction of analytes and IS from rat plasma. Consequently, acetonitrile showed relatively good recoveries from endogenous interferences in biological matrix. Absolute recoveries of all the analytes were 61.1 ± 3.2% for nodakenin, 67.3 ± 5.1% for nodakenetin, 65.7 ± 3.6% for decursinol, and 56.9 ± 4.3% for decursin/decursinol angelate. These results suggest no relevant difference of extraction recoveries at different concentration levels of all the analytes.

All stability tests were carried out using QC samples at three concentrations (0.1, 0.5, and 5.0 μg/mL). The recovered percentage of all the analytes were 97.8 ± 7.1% for nodakenin, 96.8 ± 6.3% for nodakenetin, 89.9 ± 10.6% for decursinol, and 95.2 ± 5.3% for decursin/decursinol angelate after 12 h storage at room temperature; and 99.0 ± 4.4% for nodakenin, 97.6 ± 6.8% for nodakenetin, 100.9 ± 5.9% for decursinol and 95.7 ± 5.9% for decursin/decursinol angelate after 4-weeks storage at -20°C. The postpreparative stability of analytes were 100.5 ± 6.1% for nodakenin, 101.1 ± 6.6% for nodakenetin, 97.8 ± 5.4% for decursinol, and 100.6 ± 6.5% for decursin/decursinol angelate after 24 h storage at 4°C. These results mean that the analytes did not markedly degrade during extraction procedures and storage in this study. The stability of all analytes is consistent with other reports.\[[@ref14][@ref15][@ref19]\]

### Pharmacokinetic study {#sec3-5}

The mean plasma concentration-time curves and pharmacokinetic parameters of coumarin compounds after oral administration of Samul-tang are shown in [Figure 3](#F3){ref-type="fig"} and [Table 2](#T2){ref-type="table"}, respectively. The T~max~ of nodakenin, nodakenetin, and decursinol were 9.20, 4.4, and 2.4 h, respectively. The mean C~max~ of nodakenin (1.26 versus 2.89 μg/mL), nodakenetin (0.9 versus 3.13 μg/mL), and decursinol (0.59 versus 3.09 μg/mL) significantly increased in accordance with oral doses of Samul-tang. The increases of AUC~0\ →\ t~ and AUC~0→∞~ of nodakenin, nodakenetin, and decursinol were also dependent on the oral dose. Other pharmacokinetic parameters are consistent with previously reported reports.\[[@ref14],[@ref20]\] This proposed method was successfully applied for the pharmacokinetic study of coumarin compounds in Samul-tang.

![Plasma concentration-time curves of nodakenin (a), nodakenetin (b) and decursinol (c) after oral administraion of Samul-tang (2.5 or 10.0 g/kg) in rats.](PM-10-34-g004){#F3}

###### 

Pharmacokinetics parameters of nodakenin, nodakenetin, and decursinol after oral administration of Samul-tang in rats

![](PM-10-34-g005)

Unfortunately, decursin/decursinol angelate were not detected in our study, despite to their relatively high contents in Samul-tang with respect to other coumarin compounds. Kim *et al*.,\[[@ref7]\] have reported that decursin and decursinol angelate from *A. gigas* is almost completely absorbed into blood stream with their parent forms via gastrointestinal tract and mainly excreted into feces through bile. On contrary, Park *et al*.,\[[@ref21]\] demonstrated extensive hepatic first-pass metabolism of decursin. Similar to our results, decursin in plasma was rapidly decreased after intravenous administration and only decursinol was detected after oral administration of decursin. Therefore, decursin/decursinol angelate in Samul-tang could be natural prodrugs of decursinol.

To our knowledge, albiflorin and paeoniflorin as main active compounds in Samul-tang have been centrally studied and evaluated their anticoagulation effects and pharmacokinetic properties. Apart from aforementioned compounds, however, we found the absorption and pharmacokinetic characteristics of nodakenin, nodakenetin, and decursinol to have various biological properties after oral administration of Samul-tang, which is not reported yet. Nodakenin and nodakenetin, its aglycone, has antioxidant and anti-inflammatory effect and amelioration of scopolamine-induced learning and memory impairments.\[[@ref22],[@ref23],[@ref24]\] Decursinol is well-known for its anticancer and analgesic effect, protection of septic shock, and activation of serotonergic system.\[[@ref10],[@ref25],[@ref26]\] In addition, the decursin and nodakenin from the roots of *A. gigas* exhibited antiplatelet aggregation and blood coagulation.\[[@ref8]\] Therefore, pharmacokinetic data of the coumarins in this study could provide helpful information to evaluate the pharmacological effects of Samul-tang.

CONCLUSION {#sec1-4}
==========

A simple and sensitive HPLC method with a simple LLE procedure was developed and validated for the determination of nodakenin, nodakenetin, decursinol, and decursin/decursinol angelate. This method was not only accurate and precise, but also successfully applied to a pharmacokinetic study of nodakenin, nodakenetin, and decursinol in rats.
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